The Brain on Drugs ― a Discussion with Neuroscientist Dr. Denise Milovan


This on-demand webinar focuses on the importance of including biologic and cognitive pharmacodynamic markers in your early phase clinical trials.

Presenters Dr. Beatrice Setnik and Dr. Denise Milovan unpack:

  • Strategic information collected through targeted cognitive markers 
  • How cognitive endpoints guide the design of clinical trials 
  • Specialty studies to help make informed clinical development decisions 
  • Why include biomarkers in early phase trials, including neurology and inflammation

Watch the webinar

Watch the webinar - The Brain on Drugs

To learn more about our CNS-driven solutions, speak with our experts.

You may also be interested in the following:

Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining solutions, whether for a single study or multiple programs, to offer an integrated/synchronized approach to CRO and CDMO services from lead candidate selection to clinical proof of concept, and beyond.